Statins’ effect on plasma levels of Coenzyme Q10 and improvement in myopathy with supplementation
- 1 February 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Association of Nurse Practitioners
- Vol. 26 (2) , 85-90
Abstract
Purpose Heart disease is the leading cause of death in the United States. HMG‐CoA reductase inhibitors, or statins, are medications at the forefront of the battle against cardiovascular disease. Despite their effectiveness, patient compliance with statins has lagged because of medication cost and adverse effects, namely myopathy. Myopathy is the most common side effect of statin use. The purpose of this review is to report plasma levels of CoQ10 in patients taking statins and then to determine the benefit of Coenzyme Q10 (CoQ10) supplementation on statin‐related myopathy as evidenced by symptomatic improvement and increase in serum levels of CoQ10. Data sources CINAHL, Medline, Health Source: Nursing/Academic Edition, and Cochrane Library. Conclusions Evidence from this review suggests that studies showed a significant relationship between statin intake and decreased serum levels of CoQ10. A few studies showed a benefit in symptoms of myalgia or improvement of serum levels of CoQ10 with supplementation. One study showed no benefit of CoQ10 supplementation when taken with statins. There were no risks of supplementation reported in any of the studies. Implications for Practice CoQ10 supplementation might benefit those patients suffering from statin‐induced myopathy as evidenced by the results of these studies. Supplementation of CoQ10 at a dose of between 30 and 200 mg daily has shown to have beneficial effects on statin myopathy with no noted side effects. Further research is necessary.Keywords
This publication has 18 references indexed in Scilit:
- Evidence-Based Management of Statin MyopathyCurrent Atherosclerosis Reports, 2010
- Narrative Review: Statin-Related MyopathyAnnals of Internal Medicine, 2009
- Drug-induced myopathiesCurrent Opinion in Neurology, 2008
- Effect of Coenzyme Q10 on Myopathic Symptoms in Patients Treated With StatinsThe American Journal of Cardiology, 2007
- Coenzyme Q10 in patients undergoing CABG: Effect of statins and nutritional supplementationNutrition, Metabolism and Cardiovascular Diseases, 2007
- Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in PlasmaDrug Safety, 2006
- Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemiaBioFactors, 2006
- Muscle Coenzyme Q10 Level in Statin-Related MyopathyArchives of Neurology, 2005
- Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuationBioFactors, 2005
- Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromesHuman Molecular Genetics, 2003